US Stock MarketDetailed Quotes

AVIR Atea Pharmaceuticals

Watchlist
  • 3.900
  • +0.120+3.17%
Close Aug 23 16:00 ET
  • 3.900
  • 0.0000.00%
Post 16:02 ET
329.25MMarket Cap-1857P/E (TTM)

Atea Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-161.80%-42.2M
-33.55%-39.87M
29.42%-85.4M
-1.34%-21.83M
17.19%-17.59M
15.98%-16.12M
49.41%-29.85M
-39.05%-120.98M
71.43%-21.55M
-193.98%-21.24M
Net income from continuing operations
-43.78%-40.52M
-78.11%-63.17M
-17.30%-135.96M
-13.75%-39.16M
-310.89%-33.14M
10.06%-28.18M
15.71%-35.47M
-195.64%-115.91M
-129.40%-34.43M
71.39%-8.07M
Depreciation and amortization
0.00%104K
0.00%104K
60.00%416K
0.00%104K
-1.89%104K
141.86%104K
1,385.71%104K
796.55%260K
1,385.71%104K
1,414.29%106K
Change In working capital
-447.56%-11.48M
458.37%14.1M
134.69%16.16M
127.56%9.41M
133.07%7.38M
1,443.46%3.3M
86.25%-3.94M
81.20%-46.59M
102.03%4.14M
-156.08%-22.32M
-Change in prepaid assets
461.72%3.12M
119.65%5.08M
129.82%1.86M
-135.37%-4.16M
161.19%4.57M
-131.74%-862K
740.36%2.31M
-1,194.20%-6.25M
62.74%-1.77M
-648.02%-7.48M
-Change in payables and accrued expense
-472.35%-14.56M
250.97%9.07M
136.26%14.36M
366.39%13.61M
127.66%2.85M
216.97%3.91M
79.20%-6.01M
-173.12%-39.61M
141.36%2.92M
-148.59%-10.29M
-Change in other current assets
--0
--0
106.56%98K
--0
--0
--295K
---197K
-827.95%-1.49M
-2,363.64%-1.49M
--0
-Change in other current liabilities
-10.26%-43K
-7.32%-44K
-121.05%-161K
-17.14%-41K
0.00%-40K
-104.64%-39K
---41K
--765K
---35K
---40K
Cash from discontinued investing activities
Operating cash flow
-161.80%-42.2M
-33.55%-39.87M
29.42%-85.4M
-1.34%-21.83M
17.19%-17.59M
15.98%-16.12M
49.41%-29.85M
-39.05%-120.98M
71.43%-21.55M
-193.98%-21.24M
Investing cash flow
Cash flow from continuing investing activities
167.77%124.69M
132.03%56.8M
108.85%40.3M
-17.07%27.77M
87.98%-58.51M
2,578.18%46.57M
55,736.36%24.48M
-11,385,150.00%-455.41M
837,300.00%33.49M
-486.98M
Net PPE purchase and sale
----
----
--0
--0
----
----
----
-48,475.00%-1.94M
--0
---20K
Net investment purchase and sale
167.77%124.69M
132.03%56.8M
108.89%40.3M
-17.07%27.77M
87.98%-58.51M
--46.57M
--24.48M
---453.47M
--33.49M
---486.96M
Cash from discontinued investing activities
Investing cash flow
167.77%124.69M
132.03%56.8M
108.85%40.3M
-17.07%27.77M
87.98%-58.51M
2,578.18%46.57M
55,736.36%24.48M
-11,385,150.00%-455.41M
837,300.00%33.49M
---486.98M
Financing cash flow
Cash flow from continuing financing activities
0
-9.09%150K
-30.54%257K
0
-37.41%92K
0
-26.01%165K
-74.74%370K
0
-81.51%147K
Proceeds from stock option exercised by employees
--0
-9.09%150K
-30.54%257K
--0
-37.41%92K
--0
-26.01%165K
--370K
--0
-81.51%147K
Cash from discontinued financing activities
Financing cash flow
--0
-9.09%150K
-30.54%257K
--0
-37.41%92K
--0
-26.01%165K
-74.74%370K
--0
-81.51%147K
Net cash flow
Beginning cash position
-12.29%160.91M
-23.77%143.82M
-75.33%188.66M
-21.97%137.89M
-68.76%213.9M
-74.01%183.45M
-75.33%188.66M
-10.06%764.68M
-78.96%176.72M
-16.14%684.79M
Current changes in cash
170.93%82.48M
428.28%17.09M
92.22%-44.84M
-50.29%5.94M
85.04%-76.01M
244.53%30.45M
91.15%-5.21M
-573.36%-576.02M
115.86%11.94M
-2,271.42%-508.07M
End cash Position
13.79%243.39M
-12.29%160.91M
-23.77%143.82M
-23.77%143.82M
-21.97%137.89M
-68.76%213.9M
-74.01%183.45M
-75.33%188.66M
-75.33%188.66M
-78.96%176.72M
Free cash flow
-161.80%-42.2M
-33.55%-39.87M
30.53%-85.4M
-1.34%-21.83M
17.27%-17.59M
23.47%-16.12M
49.45%-29.85M
-41.28%-122.93M
71.44%-21.55M
-194.07%-21.26M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -161.80%-42.2M-33.55%-39.87M29.42%-85.4M-1.34%-21.83M17.19%-17.59M15.98%-16.12M49.41%-29.85M-39.05%-120.98M71.43%-21.55M-193.98%-21.24M
Net income from continuing operations -43.78%-40.52M-78.11%-63.17M-17.30%-135.96M-13.75%-39.16M-310.89%-33.14M10.06%-28.18M15.71%-35.47M-195.64%-115.91M-129.40%-34.43M71.39%-8.07M
Depreciation and amortization 0.00%104K0.00%104K60.00%416K0.00%104K-1.89%104K141.86%104K1,385.71%104K796.55%260K1,385.71%104K1,414.29%106K
Change In working capital -447.56%-11.48M458.37%14.1M134.69%16.16M127.56%9.41M133.07%7.38M1,443.46%3.3M86.25%-3.94M81.20%-46.59M102.03%4.14M-156.08%-22.32M
-Change in prepaid assets 461.72%3.12M119.65%5.08M129.82%1.86M-135.37%-4.16M161.19%4.57M-131.74%-862K740.36%2.31M-1,194.20%-6.25M62.74%-1.77M-648.02%-7.48M
-Change in payables and accrued expense -472.35%-14.56M250.97%9.07M136.26%14.36M366.39%13.61M127.66%2.85M216.97%3.91M79.20%-6.01M-173.12%-39.61M141.36%2.92M-148.59%-10.29M
-Change in other current assets --0--0106.56%98K--0--0--295K---197K-827.95%-1.49M-2,363.64%-1.49M--0
-Change in other current liabilities -10.26%-43K-7.32%-44K-121.05%-161K-17.14%-41K0.00%-40K-104.64%-39K---41K--765K---35K---40K
Cash from discontinued investing activities
Operating cash flow -161.80%-42.2M-33.55%-39.87M29.42%-85.4M-1.34%-21.83M17.19%-17.59M15.98%-16.12M49.41%-29.85M-39.05%-120.98M71.43%-21.55M-193.98%-21.24M
Investing cash flow
Cash flow from continuing investing activities 167.77%124.69M132.03%56.8M108.85%40.3M-17.07%27.77M87.98%-58.51M2,578.18%46.57M55,736.36%24.48M-11,385,150.00%-455.41M837,300.00%33.49M-486.98M
Net PPE purchase and sale ----------0--0-------------48,475.00%-1.94M--0---20K
Net investment purchase and sale 167.77%124.69M132.03%56.8M108.89%40.3M-17.07%27.77M87.98%-58.51M--46.57M--24.48M---453.47M--33.49M---486.96M
Cash from discontinued investing activities
Investing cash flow 167.77%124.69M132.03%56.8M108.85%40.3M-17.07%27.77M87.98%-58.51M2,578.18%46.57M55,736.36%24.48M-11,385,150.00%-455.41M837,300.00%33.49M---486.98M
Financing cash flow
Cash flow from continuing financing activities 0-9.09%150K-30.54%257K0-37.41%92K0-26.01%165K-74.74%370K0-81.51%147K
Proceeds from stock option exercised by employees --0-9.09%150K-30.54%257K--0-37.41%92K--0-26.01%165K--370K--0-81.51%147K
Cash from discontinued financing activities
Financing cash flow --0-9.09%150K-30.54%257K--0-37.41%92K--0-26.01%165K-74.74%370K--0-81.51%147K
Net cash flow
Beginning cash position -12.29%160.91M-23.77%143.82M-75.33%188.66M-21.97%137.89M-68.76%213.9M-74.01%183.45M-75.33%188.66M-10.06%764.68M-78.96%176.72M-16.14%684.79M
Current changes in cash 170.93%82.48M428.28%17.09M92.22%-44.84M-50.29%5.94M85.04%-76.01M244.53%30.45M91.15%-5.21M-573.36%-576.02M115.86%11.94M-2,271.42%-508.07M
End cash Position 13.79%243.39M-12.29%160.91M-23.77%143.82M-23.77%143.82M-21.97%137.89M-68.76%213.9M-74.01%183.45M-75.33%188.66M-75.33%188.66M-78.96%176.72M
Free cash flow -161.80%-42.2M-33.55%-39.87M30.53%-85.4M-1.34%-21.83M17.27%-17.59M23.47%-16.12M49.45%-29.85M-41.28%-122.93M71.44%-21.55M-194.07%-21.26M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg